Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rora
|
ENSMUSG00000032238.11 | RAR-related orphan receptor alpha |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_68653279_68654333 | Rora | 20 | 0.986765 | 0.62 | 4.2e-07 | Click! |
chr9_68923367_68923550 | Rora | 268155 | 0.015215 | 0.54 | 2.4e-05 | Click! |
chr9_68842498_68842649 | Rora | 187270 | 0.029447 | 0.53 | 2.7e-05 | Click! |
chr9_68923153_68923304 | Rora | 267925 | 0.015240 | 0.51 | 7.8e-05 | Click! |
chr9_68654694_68654845 | Rora | 534 | 0.855406 | 0.50 | 1.1e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_125617408_125617804 | 14.05 |
Cep152 |
centrosomal protein 152 |
7507 |
0.23 |
chr8_125401477_125401784 | 6.80 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
91080 |
0.09 |
chr4_110050502_110051534 | 5.23 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chrX_73384573_73384724 | 4.92 |
Gm18336 |
predicted gene, 18336 |
14088 |
0.09 |
chr2_34486214_34486378 | 4.80 |
Mapkap1 |
mitogen-activated protein kinase associated protein 1 |
41949 |
0.13 |
chr12_3236518_3237725 | 4.31 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr10_128381022_128381494 | 4.09 |
Mir6914 |
microRNA 6914 |
1580 |
0.13 |
chr6_22795399_22795769 | 4.06 |
Gm25942 |
predicted gene, 25942 |
5766 |
0.17 |
chr13_23226264_23226415 | 4.02 |
Vmn1r-ps133 |
vomeronasal 1 receptor, pseudogene 133 |
2413 |
0.12 |
chr8_55025881_55026035 | 3.87 |
Gm45264 |
predicted gene 45264 |
2443 |
0.21 |
chr12_29871996_29872873 | 3.84 |
Myt1l |
myelin transcription factor 1-like |
20886 |
0.24 |
chr12_28860065_28860473 | 3.78 |
Eipr1 |
EARP complex and GARP complex interacting protein 1 |
2580 |
0.25 |
chr13_93637737_93637888 | 3.76 |
Bhmt |
betaine-homocysteine methyltransferase |
149 |
0.95 |
chr7_31127074_31128340 | 3.71 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr6_103307293_103307469 | 3.60 |
Gm44295 |
predicted gene, 44295 |
27395 |
0.24 |
chr3_105214990_105215277 | 3.53 |
4930564D02Rik |
RIKEN cDNA 4930564D02 gene |
148289 |
0.04 |
chr18_37178883_37179113 | 3.53 |
Gm10544 |
predicted gene 10544 |
476 |
0.71 |
chr3_141936600_141936978 | 3.48 |
Bmpr1b |
bone morphogenetic protein receptor, type 1B |
5266 |
0.33 |
chr8_94154535_94154978 | 3.48 |
Mt3 |
metallothionein 3 |
2010 |
0.19 |
chr19_61225302_61226760 | 3.44 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr15_32172538_32172721 | 3.42 |
Tas2r119 |
taste receptor, type 2, member 119 |
4660 |
0.24 |
chr9_115604305_115604456 | 3.39 |
n-R5s92 |
nuclear encoded rRNA 5S 92 |
22338 |
0.2 |
chr4_82945870_82946062 | 3.33 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
5084 |
0.27 |
chr19_36677279_36677798 | 3.32 |
Hectd2os |
Hectd2, opposite strand |
11735 |
0.22 |
chr11_54303609_54304215 | 3.29 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
93 |
0.96 |
chr16_63747767_63748162 | 3.27 |
Gm22769 |
predicted gene, 22769 |
430 |
0.91 |
chr10_69465967_69466180 | 3.26 |
Gm18636 |
predicted gene, 18636 |
42325 |
0.15 |
chr1_120115905_120116482 | 3.24 |
Dbi |
diazepam binding inhibitor |
3945 |
0.21 |
chr15_67898912_67899432 | 3.22 |
Gm49408 |
predicted gene, 49408 |
25344 |
0.23 |
chr13_54212389_54212540 | 3.19 |
Hrh2 |
histamine receptor H2 |
1543 |
0.35 |
chr3_157321061_157321436 | 3.19 |
Gm22458 |
predicted gene, 22458 |
44750 |
0.14 |
chr14_14350947_14351733 | 3.18 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr7_139530797_139531163 | 3.18 |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
7122 |
0.23 |
chr1_56834200_56834567 | 3.17 |
Satb2 |
special AT-rich sequence binding protein 2 |
135457 |
0.05 |
chr13_54390595_54390767 | 3.16 |
Gm16248 |
predicted gene 16248 |
8653 |
0.16 |
chr16_37584654_37585373 | 3.15 |
Hgd |
homogentisate 1, 2-dioxygenase |
4731 |
0.16 |
chr15_52161658_52161900 | 3.14 |
Gm2387 |
predicted gene 2387 |
72471 |
0.1 |
chr16_65565056_65565226 | 3.06 |
Chmp2b |
charged multivesicular body protein 2B |
2415 |
0.3 |
chr1_85922952_85923123 | 3.02 |
4933407L21Rik |
RIKEN cDNA 4933407L21 gene |
5446 |
0.14 |
chr5_120490584_120491079 | 2.99 |
Gm15690 |
predicted gene 15690 |
9928 |
0.1 |
chr8_123412020_123412219 | 2.94 |
Tubb3 |
tubulin, beta 3 class III |
529 |
0.53 |
chr14_14349938_14350878 | 2.90 |
Il3ra |
interleukin 3 receptor, alpha chain |
787 |
0.48 |
chr1_92224585_92224856 | 2.86 |
Hdac4 |
histone deacetylase 4 |
29021 |
0.2 |
chr7_28693566_28694015 | 2.85 |
Fbxo27 |
F-box protein 27 |
229 |
0.87 |
chr7_113250698_113250986 | 2.85 |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
11088 |
0.2 |
chr17_56487709_56487889 | 2.85 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
11316 |
0.14 |
chr12_29697889_29698089 | 2.83 |
C630031E19Rik |
RIKEN cDNA C630031E19 gene |
11544 |
0.29 |
chr13_23949732_23949947 | 2.82 |
Scgn |
secretagogin, EF-hand calcium binding protein |
5740 |
0.1 |
chr16_72088914_72089089 | 2.82 |
8030451O07Rik |
RIKEN cDNA 8030451O07 gene |
145301 |
0.04 |
chr3_17789298_17789482 | 2.80 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
531 |
0.77 |
chr4_116016940_116018214 | 2.77 |
Faah |
fatty acid amide hydrolase |
98 |
0.95 |
chr6_16317315_16317509 | 2.77 |
Gm3148 |
predicted gene 3148 |
79785 |
0.1 |
chr4_35125928_35126141 | 2.73 |
Ifnk |
interferon kappa |
26022 |
0.16 |
chr2_21060109_21060286 | 2.72 |
Gm13376 |
predicted gene 13376 |
36902 |
0.16 |
chr14_64589182_64589588 | 2.71 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
310 |
0.8 |
chr3_6106672_6106878 | 2.69 |
Gm17934 |
predicted gene, 17934 |
31469 |
0.2 |
chr1_190956801_190956952 | 2.68 |
Angel2 |
angel homolog 2 |
19624 |
0.11 |
chr2_91399567_91399718 | 2.67 |
Gm22071 |
predicted gene, 22071 |
7494 |
0.17 |
chr4_86183702_86183912 | 2.66 |
Adamtsl1 |
ADAMTS-like 1 |
15510 |
0.29 |
chr12_42138774_42139142 | 2.62 |
Gm47020 |
predicted gene, 47020 |
12882 |
0.24 |
chr8_95703143_95704225 | 2.58 |
Ndrg4 |
N-myc downstream regulated gene 4 |
614 |
0.57 |
chr13_59040586_59040898 | 2.57 |
Gm34245 |
predicted gene, 34245 |
37554 |
0.14 |
chr9_43699339_43700154 | 2.55 |
Gm5364 |
predicted gene 5364 |
16693 |
0.14 |
chr3_17619540_17619872 | 2.50 |
Gm38154 |
predicted gene, 38154 |
50982 |
0.17 |
chr17_66479760_66480028 | 2.49 |
Rab12 |
RAB12, member RAS oncogene family |
20425 |
0.14 |
chr6_77980120_77980374 | 2.49 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
548 |
0.8 |
chr10_85161847_85162049 | 2.49 |
Cry1 |
cryptochrome 1 (photolyase-like) |
10592 |
0.18 |
chr1_38848739_38848890 | 2.49 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
12103 |
0.16 |
chr1_25107573_25107724 | 2.46 |
Gm29414 |
predicted gene 29414 |
80416 |
0.07 |
chr3_134237274_134237500 | 2.46 |
Cxxc4 |
CXXC finger 4 |
567 |
0.65 |
chr6_48554363_48554560 | 2.45 |
Lrrc61 |
leucine rich repeat containing 61 |
335 |
0.7 |
chr1_112379892_112380215 | 2.45 |
Gm18406 |
predicted gene, 18406 |
24802 |
0.25 |
chr10_56228886_56229075 | 2.45 |
Tbc1d32 |
TBC1 domain family, member 32 |
291 |
0.94 |
chr6_39242951_39243777 | 2.44 |
Gm43479 |
predicted gene 43479 |
3250 |
0.2 |
chr6_11061039_11061254 | 2.43 |
AA545190 |
EST AA545190 |
81508 |
0.11 |
chr15_8865676_8865862 | 2.42 |
Gm5043 |
predicted gene 5043 |
48715 |
0.14 |
chr10_13835867_13836018 | 2.41 |
Aig1 |
androgen-induced 1 |
8344 |
0.18 |
chr2_17839635_17839891 | 2.39 |
Gm13323 |
predicted gene 13323 |
41779 |
0.17 |
chr5_105823184_105823480 | 2.36 |
Lrrc8d |
leucine rich repeat containing 8D |
1179 |
0.39 |
chr1_172343801_172343952 | 2.36 |
Kcnj10 |
potassium inwardly-rectifying channel, subfamily J, member 10 |
2666 |
0.16 |
chr19_10784841_10784992 | 2.35 |
A430093F15Rik |
RIKEN cDNA A430093F15 gene |
436 |
0.74 |
chr1_171223870_171224084 | 2.35 |
Apoa2 |
apolipoprotein A-II |
1077 |
0.24 |
chr3_126695393_126695856 | 2.34 |
Gm15551 |
predicted gene 15551 |
26580 |
0.11 |
chr7_17074245_17074442 | 2.34 |
Psg16 |
pregnancy specific glycoprotein 16 |
225 |
0.88 |
chr12_29353798_29354061 | 2.33 |
Gm6989 |
predicted gene 6989 |
36361 |
0.21 |
chr1_72823832_72824380 | 2.33 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
397 |
0.88 |
chr16_78303818_78303969 | 2.32 |
E330011O21Rik |
RIKEN cDNA E330011O21 gene |
1406 |
0.33 |
chr9_16014090_16014288 | 2.32 |
Fat3 |
FAT atypical cadherin 3 |
7439 |
0.3 |
chr1_39086302_39086453 | 2.29 |
Gm37091 |
predicted gene, 37091 |
3039 |
0.25 |
chr18_28077821_28078065 | 2.29 |
Gm5064 |
predicted gene 5064 |
110874 |
0.07 |
chr2_157479944_157480127 | 2.29 |
Src |
Rous sarcoma oncogene |
22950 |
0.13 |
chr7_44590495_44590984 | 2.28 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
75 |
0.54 |
chr3_79818299_79818691 | 2.28 |
Gm26420 |
predicted gene, 26420 |
16438 |
0.17 |
chr12_37988361_37988598 | 2.28 |
Dgkb |
diacylglycerol kinase, beta |
29235 |
0.2 |
chr7_43488630_43488974 | 2.27 |
Iglon5 |
IgLON family member 5 |
1273 |
0.21 |
chr6_53855155_53855476 | 2.27 |
Gm22910 |
predicted gene, 22910 |
16833 |
0.18 |
chr17_93201568_93201863 | 2.27 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
361 |
0.87 |
chr4_107020383_107020534 | 2.27 |
Gm12786 |
predicted gene 12786 |
2041 |
0.27 |
chr2_73604755_73604906 | 2.25 |
Chn1os3 |
chimerin 1, opposite strand 3 |
8006 |
0.15 |
chr5_8368337_8368581 | 2.25 |
Adam22 |
a disintegrin and metallopeptidase domain 22 |
299 |
0.9 |
chr8_70600399_70601192 | 2.24 |
Ssbp4 |
single stranded DNA binding protein 4 |
886 |
0.36 |
chr13_99514035_99514335 | 2.23 |
Map1b |
microtubule-associated protein 1B |
2333 |
0.23 |
chr1_158246837_158247129 | 2.23 |
Brinp2 |
bone morphogenic protein/retinoic acid inducible neural-specific 2 |
49481 |
0.17 |
chr7_132153712_132153922 | 2.23 |
Gm15677 |
predicted gene 15677 |
354 |
0.74 |
chr10_37357654_37357993 | 2.23 |
Gm26535 |
predicted gene, 26535 |
20337 |
0.25 |
chr7_140081338_140081688 | 2.22 |
Caly |
calcyon neuron-specific vesicular protein |
714 |
0.46 |
chr9_65744282_65744624 | 2.22 |
Zfp609 |
zinc finger protein 609 |
43309 |
0.11 |
chrX_74282355_74283413 | 2.22 |
Taz |
tafazzin |
37 |
0.86 |
chr11_90548602_90548985 | 2.21 |
Stxbp4 |
syntaxin binding protein 4 |
117 |
0.97 |
chr3_4278159_4278326 | 2.21 |
Gm23976 |
predicted gene, 23976 |
27051 |
0.19 |
chr2_165136576_165136762 | 2.21 |
Gm14397 |
predicted gene 14397 |
22743 |
0.14 |
chr6_29814718_29814912 | 2.20 |
Ahcyl2 |
S-adenosylhomocysteine hydrolase-like 2 |
12956 |
0.18 |
chr11_75509773_75510993 | 2.20 |
Rilp |
Rab interacting lysosomal protein |
84 |
0.93 |
chr7_90029047_90029198 | 2.19 |
E230029C05Rik |
RIKEN cDNA E230029C05 gene |
37 |
0.95 |
chr4_107829775_107830223 | 2.18 |
Lrp8os1 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor, opposite strand 1 |
845 |
0.35 |
chr3_41408793_41409655 | 2.18 |
Gm25487 |
predicted gene, 25487 |
32243 |
0.14 |
chr14_52003889_52004971 | 2.17 |
Arhgef40 |
Rho guanine nucleotide exchange factor (GEF) 40 |
58 |
0.93 |
chr5_20056465_20056826 | 2.16 |
Gm23570 |
predicted gene, 23570 |
35970 |
0.2 |
chr10_60277270_60277501 | 2.16 |
Psap |
prosaposin |
242 |
0.93 |
chr10_37378360_37378791 | 2.16 |
Gm26535 |
predicted gene, 26535 |
41089 |
0.18 |
chr6_121473518_121474161 | 2.16 |
Iqsec3 |
IQ motif and Sec7 domain 3 |
161 |
0.96 |
chr19_21781727_21782179 | 2.15 |
Cemip2 |
cell migration inducing hyaluronidase 2 |
3565 |
0.26 |
chr7_79532599_79532750 | 2.15 |
Gm35040 |
predicted gene, 35040 |
3369 |
0.12 |
chr6_81596035_81596186 | 2.15 |
Gm26264 |
predicted gene, 26264 |
42201 |
0.19 |
chr16_63806861_63807216 | 2.14 |
Epha3 |
Eph receptor A3 |
56375 |
0.15 |
chr14_75025244_75025395 | 2.14 |
Rubcnl |
RUN and cysteine rich domain containing beclin 1 interacting protein like |
9292 |
0.2 |
chr2_127353943_127354094 | 2.14 |
Adra2b |
adrenergic receptor, alpha 2b |
9190 |
0.13 |
chr9_96493315_96493466 | 2.14 |
Gm27289 |
predicted gene, 27289 |
1823 |
0.25 |
chr3_36862669_36863444 | 2.14 |
4932438A13Rik |
RIKEN cDNA 4932438A13 gene |
48 |
0.98 |
chr18_16791395_16791546 | 2.13 |
Cdh2 |
cadherin 2 |
16992 |
0.19 |
chr12_39301586_39301824 | 2.12 |
Gm18591 |
predicted gene, 18591 |
92813 |
0.08 |
chr11_12589839_12590029 | 2.11 |
Gm22156 |
predicted gene, 22156 |
86999 |
0.09 |
chr12_28460953_28461147 | 2.11 |
Dcdc2c |
doublecortin domain containing 2C |
55664 |
0.11 |
chr12_12812921_12813270 | 2.11 |
Platr19 |
pluripotency associated transcript 19 |
25110 |
0.16 |
chr15_36943512_36944089 | 2.11 |
Gm34590 |
predicted gene, 34590 |
4936 |
0.18 |
chr9_99744585_99744739 | 2.10 |
Gm23949 |
predicted gene, 23949 |
5855 |
0.19 |
chr6_25689341_25689687 | 2.10 |
Gpr37 |
G protein-coupled receptor 37 |
278 |
0.95 |
chr15_35937613_35937820 | 2.09 |
Cox6c |
cytochrome c oxidase subunit 6C |
71 |
0.98 |
chr13_84349064_84349215 | 2.09 |
Gm26927 |
predicted gene, 26927 |
9026 |
0.23 |
chrX_134296200_134296480 | 2.09 |
Tmem35a |
transmembrane protein 35A |
1115 |
0.45 |
chr4_59629532_59629743 | 2.08 |
E130308A19Rik |
RIKEN cDNA E130308A19 gene |
3394 |
0.25 |
chr2_78064381_78064581 | 2.08 |
4930440I19Rik |
RIKEN cDNA 4930440I19 gene |
13258 |
0.27 |
chr13_35345593_35345770 | 2.07 |
Gm48703 |
predicted gene, 48703 |
49702 |
0.12 |
chr11_94327762_94328694 | 2.07 |
Ankrd40 |
ankyrin repeat domain 40 |
26 |
0.97 |
chr2_10374243_10374943 | 2.07 |
Gm13261 |
predicted gene 13261 |
552 |
0.39 |
chr5_43236135_43236286 | 2.06 |
Gm7854 |
predicted gene 7854 |
855 |
0.43 |
chr3_136007931_136008143 | 2.06 |
Gm5281 |
predicted gene 5281 |
43651 |
0.12 |
chr10_29147727_29147900 | 2.05 |
Soga3 |
SOGA family member 3 |
16 |
0.97 |
chr1_164704491_164704691 | 2.05 |
Gm37853 |
predicted gene, 37853 |
6358 |
0.17 |
chr1_128585767_128586184 | 2.05 |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
6315 |
0.21 |
chr13_21897327_21897714 | 2.04 |
Mir1983 |
microRNA 1983 |
471 |
0.57 |
chr13_55327368_55327678 | 2.03 |
Mxd3 |
Max dimerization protein 3 |
1829 |
0.2 |
chr4_132744073_132744224 | 2.03 |
Xkr8 |
X-linked Kx blood group related 8 |
11602 |
0.12 |
chr4_72184619_72184770 | 2.03 |
Tle1 |
transducin-like enhancer of split 1 |
14398 |
0.19 |
chr5_84153090_84153587 | 2.03 |
Hmgn2-ps1 |
high mobility group nucleosomal binding domain 2, pseudogene 1 |
30025 |
0.25 |
chr4_32480421_32480572 | 2.02 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
21009 |
0.22 |
chr4_22477378_22477742 | 2.01 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
10806 |
0.16 |
chr4_107783634_107783785 | 2.01 |
4933424M12Rik |
RIKEN cDNA 4933424M12 gene |
11 |
0.96 |
chr9_13246797_13247848 | 2.01 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr4_100973634_100974412 | 2.00 |
Cachd1 |
cache domain containing 1 |
20588 |
0.19 |
chr8_4238910_4239597 | 2.00 |
Gm49320 |
predicted gene, 49320 |
388 |
0.44 |
chr2_144127511_144127732 | 2.00 |
Gm11687 |
predicted gene 11687 |
15752 |
0.16 |
chr11_57011183_57011334 | 1.99 |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
129 |
0.98 |
chr2_22986112_22986263 | 1.98 |
Abi1 |
abl-interactor 1 |
23576 |
0.14 |
chr19_47854442_47855082 | 1.98 |
Gsto1 |
glutathione S-transferase omega 1 |
208 |
0.92 |
chr10_17411357_17411707 | 1.98 |
Gm47760 |
predicted gene, 47760 |
78655 |
0.09 |
chr17_9726102_9726458 | 1.98 |
Gm34684 |
predicted gene, 34684 |
73 |
0.98 |
chr13_83718584_83718791 | 1.96 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2694 |
0.19 |
chr5_31297157_31297308 | 1.96 |
Gckr |
glucokinase regulatory protein |
211 |
0.84 |
chr11_6604571_6604755 | 1.96 |
Nacad |
NAC alpha domain containing |
1390 |
0.22 |
chr4_97911321_97911484 | 1.96 |
Nfia |
nuclear factor I/A |
369 |
0.92 |
chr11_9048628_9049171 | 1.96 |
Sun3 |
Sad1 and UNC84 domain containing 3 |
92 |
0.77 |
chrX_20961484_20961793 | 1.96 |
A230072C01Rik |
RIKEN cDNA A230072C01 gene |
46 |
0.77 |
chr4_57091378_57091763 | 1.96 |
Epb41l4b |
erythrocyte membrane protein band 4.1 like 4b |
11883 |
0.23 |
chr15_79695574_79695970 | 1.96 |
Gtpbp1 |
GTP binding protein 1 |
1592 |
0.19 |
chr12_103164655_103164890 | 1.95 |
Unc79 |
unc-79 homolog |
30231 |
0.15 |
chr11_117336202_117336679 | 1.95 |
Septin9 |
septin 9 |
4012 |
0.23 |
chr12_85619875_85620071 | 1.95 |
Jdp2 |
Jun dimerization protein 2 |
17751 |
0.14 |
chr2_156666341_156666675 | 1.94 |
Gm14172 |
predicted gene 14172 |
33040 |
0.1 |
chr1_132557859_132558597 | 1.94 |
Cntn2 |
contactin 2 |
14972 |
0.16 |
chr19_10341893_10342454 | 1.94 |
Dagla |
diacylglycerol lipase, alpha |
37296 |
0.11 |
chr11_74589556_74589981 | 1.93 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
356 |
0.87 |
chr10_100111276_100111504 | 1.93 |
Kitl |
kit ligand |
23334 |
0.13 |
chr4_104303359_104303510 | 1.92 |
Dab1 |
disabled 1 |
63679 |
0.15 |
chr1_155843635_155843786 | 1.92 |
Gm38038 |
predicted gene, 38038 |
11739 |
0.11 |
chr7_62462279_62462935 | 1.91 |
Peg12 |
paternally expressed 12 |
1903 |
0.3 |
chr4_32530914_32531132 | 1.91 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
29518 |
0.16 |
chr1_32172144_32172438 | 1.91 |
Khdrbs2 |
KH domain containing, RNA binding, signal transduction associated 2 |
423 |
0.89 |
chr13_63230991_63231626 | 1.91 |
Aopep |
aminopeptidase O |
8721 |
0.11 |
chr11_18115601_18116106 | 1.91 |
Gm12018 |
predicted gene 12018 |
19867 |
0.24 |
chr13_94375770_94375965 | 1.89 |
Ap3b1 |
adaptor-related protein complex 3, beta 1 subunit |
16907 |
0.17 |
chr2_49620647_49620914 | 1.89 |
Kif5c |
kinesin family member 5C |
1482 |
0.5 |
chr17_15377996_15378323 | 1.89 |
Dll1 |
delta like canonical Notch ligand 1 |
1287 |
0.39 |
chr13_112288004_112288571 | 1.89 |
Ankrd55 |
ankyrin repeat domain 55 |
164 |
0.95 |
chr13_18868947_18869098 | 1.88 |
Vps41 |
VPS41 HOPS complex subunit |
24159 |
0.18 |
chr2_152375831_152376029 | 1.88 |
Nrsn2 |
neurensin 2 |
708 |
0.41 |
chr4_122998402_122999232 | 1.88 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
63 |
0.96 |
chr3_101145898_101146084 | 1.88 |
Ptgfrn |
prostaglandin F2 receptor negative regulator |
35713 |
0.14 |
chr3_94484401_94484863 | 1.88 |
Celf3 |
CUGBP, Elav-like family member 3 |
261 |
0.81 |
chr10_62338357_62339018 | 1.87 |
Hk1os |
hexokinase 1, opposite strand |
1569 |
0.3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.8 | 2.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.8 | 3.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.7 | 2.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.7 | 4.0 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.7 | 2.6 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.6 | 1.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.6 | 3.8 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.6 | 1.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.6 | 1.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.5 | 1.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.5 | 1.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 2.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.5 | 1.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 1.0 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.5 | 1.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.5 | 2.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.5 | 3.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.5 | 1.4 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.5 | 1.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 1.7 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.4 | 0.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 1.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.4 | 2.5 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
0.4 | 0.4 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.4 | 4.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.4 | 1.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.4 | 0.4 | GO:0008038 | neuron recognition(GO:0008038) |
0.4 | 1.6 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.4 | 2.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.4 | 1.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 1.9 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.4 | 1.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 0.7 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.4 | 1.1 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 1.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.4 | 2.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.3 | 1.4 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.3 | 1.7 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.3 | 1.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 1.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 1.0 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 1.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 1.7 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.3 | 1.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 1.3 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.3 | 1.0 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 1.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 1.0 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.3 | 1.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.3 | 0.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 0.9 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.3 | 0.9 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 0.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 0.9 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.3 | 1.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 0.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 0.8 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.3 | 1.6 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.3 | 2.4 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 0.8 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.3 | 3.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 0.8 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.3 | 1.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 0.5 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.3 | 0.8 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.3 | 0.8 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 0.5 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.2 | 1.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 1.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.7 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.2 | 0.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.7 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 1.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.7 | GO:0046959 | habituation(GO:0046959) |
0.2 | 1.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 0.5 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.2 | 0.7 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 0.5 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 0.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 1.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 0.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.2 | 0.7 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 0.2 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.2 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 1.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 1.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 0.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.2 | 0.4 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 3.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 1.5 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 1.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 1.9 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 0.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 2.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.2 | 1.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.6 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 0.4 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 1.0 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.2 | 0.4 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.2 | 0.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.6 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.2 | 1.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 1.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.2 | 0.6 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.2 | 0.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.2 | 0.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 1.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.2 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.2 | 0.6 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.6 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.2 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.5 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.2 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.4 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.9 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.2 | 0.9 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.2 | 0.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 1.9 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 0.9 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.9 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 0.3 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 0.5 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.2 | 2.9 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 0.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.2 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 0.8 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.2 | 0.8 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 0.5 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.2 | 0.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 3.1 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.2 | 0.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.2 | 1.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 1.3 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 1.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 1.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 0.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.2 | 0.5 | GO:0048143 | astrocyte activation(GO:0048143) |
0.2 | 0.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 1.7 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.2 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 0.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.2 | 0.3 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.2 | 1.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.4 | GO:0043217 | myelin maintenance(GO:0043217) |
0.1 | 0.9 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.4 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.4 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 3.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.9 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.6 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.1 | 0.4 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.4 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 0.6 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.1 | 1.4 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 1.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 1.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 1.0 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.1 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.1 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 2.3 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.3 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.8 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.4 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.1 | 0.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.5 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.1 | GO:0015846 | polyamine transport(GO:0015846) |
0.1 | 0.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 1.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 2.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.4 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) |
0.1 | 0.7 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.4 | GO:1904395 | positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.1 | 1.0 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.4 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.1 | 0.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.1 | 1.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.4 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.9 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.3 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 1.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.6 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 1.7 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 1.5 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.4 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.1 | 0.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 2.5 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.6 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.4 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 0.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.8 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 1.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.4 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 1.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.1 | 0.3 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.3 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.1 | 0.1 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 1.4 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.5 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 1.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.3 | GO:0061010 | gall bladder development(GO:0061010) |
0.1 | 0.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.3 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.3 | GO:0043090 | amino acid import(GO:0043090) |
0.1 | 0.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.8 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.1 | 0.1 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 0.8 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.4 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.2 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.4 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.7 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.4 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.7 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.1 | 0.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 1.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.1 | 1.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.2 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 1.2 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 1.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.2 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.1 | 0.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.7 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.9 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.8 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.4 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.2 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.3 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.1 | 0.6 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 1.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.6 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.1 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.1 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.3 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.9 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.7 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.1 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.1 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.5 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 2.0 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.2 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 1.9 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 1.6 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.3 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.3 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.2 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.8 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.3 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.2 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 3.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.2 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.1 | GO:0072611 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.1 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 1.2 | GO:0051647 | nucleus localization(GO:0051647) |
0.1 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.1 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.4 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.2 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.2 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.8 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 1.2 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.1 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.1 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.3 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.1 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.7 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.1 | 0.6 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.1 | GO:0060513 | prostatic bud formation(GO:0060513) lateral sprouting from an epithelium(GO:0060601) regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.3 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.2 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.1 | GO:2000543 | deltoid tuberosity development(GO:0035993) positive regulation of gastrulation(GO:2000543) |
0.1 | 2.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.1 | 0.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.2 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.1 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.6 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.1 | 0.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.4 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.1 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 1.1 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.8 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.1 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.1 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.6 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.3 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 0.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.1 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 1.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.2 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 1.3 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.7 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.8 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.6 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.6 | GO:0032402 | melanosome transport(GO:0032402) |
0.1 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.1 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.1 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.1 | 0.1 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.1 | 0.1 | GO:0061642 | chemoattraction of axon(GO:0061642) chemorepulsion of axon(GO:0061643) |
0.1 | 0.3 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.8 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.7 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.3 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.3 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.7 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 1.4 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.3 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.5 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.1 | 0.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.1 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.3 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.1 | 0.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.8 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.7 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 0.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 1.3 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 0.1 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.1 | 0.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.4 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.0 | 0.0 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 1.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.0 | 0.9 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 0.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.0 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 0.1 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.0 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 1.0 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 1.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) negative regulation of glucokinase activity(GO:0033132) regulation of hexokinase activity(GO:1903299) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.0 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.4 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.5 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.0 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.0 | 0.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 0.1 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
0.0 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.1 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 1.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.1 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.0 | 0.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.0 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 4.2 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.0 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.0 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.0 | 0.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.0 | 0.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.0 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.0 | 0.3 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.1 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.0 | 0.2 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.2 | GO:1902583 | transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.0 | 0.0 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.0 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.0 | 0.3 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.1 | GO:0035931 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 0.0 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.0 | 0.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.1 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.1 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 1.4 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.0 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.2 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.0 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.0 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.0 | 0.0 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.1 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.1 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.0 | 0.1 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.0 | 0.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.0 | 0.0 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.0 | 0.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.3 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.0 | 0.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.0 | 0.0 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.0 | 0.5 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.5 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.2 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.0 | 0.6 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.0 | 0.0 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.0 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.0 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.3 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.0 | 0.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 2.0 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.0 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.0 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.2 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.0 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0060440 | trachea formation(GO:0060440) regulation of Golgi inheritance(GO:0090170) |
0.0 | 0.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.6 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.2 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.9 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.1 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.0 | 0.1 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.1 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.1 | GO:0098868 | bone growth(GO:0098868) |
0.0 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.0 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.0 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 1.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.1 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.5 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.0 | 0.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.0 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 0.1 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.0 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.0 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
0.0 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.0 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.0 | 0.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 1.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.0 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.0 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.2 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.0 | 0.3 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.0 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.5 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.0 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.2 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 0.0 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.0 | GO:0008050 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.0 | 0.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 1.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.1 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.0 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.0 | 0.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.0 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.0 | 0.3 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
0.0 | 0.1 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.0 | 0.1 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.2 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.4 | GO:0048806 | genitalia development(GO:0048806) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.0 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 0.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.0 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.0 | 0.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.0 | 0.2 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.0 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.0 | 0.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.0 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.0 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.0 | 0.0 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.0 | 0.0 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.0 | 0.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.2 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.0 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.0 | 0.0 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.4 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.2 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.0 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.0 | 0.3 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.0 | 0.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.2 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.0 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.1 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.0 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.0 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.0 | 0.0 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.0 | 0.0 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.5 | GO:0033141 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.3 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.0 | 0.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.0 | 0.0 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.1 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.0 | 0.0 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.0 | 0.1 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.0 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.3 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.1 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.6 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 0.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.0 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.0 | 0.5 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.0 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.1 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.0 | 0.0 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.0 | 0.0 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.0 | 0.0 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.0 | 0.1 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.0 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.0 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.0 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) |
0.0 | 0.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.0 | 0.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.0 | GO:0072683 | T cell extravasation(GO:0072683) |
0.0 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.0 | 0.0 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.0 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.1 | GO:0098536 | deuterosome(GO:0098536) |
0.6 | 2.4 | GO:0044308 | axonal spine(GO:0044308) |
0.5 | 0.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.5 | 1.5 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.5 | 2.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 1.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 3.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 1.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 2.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 1.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 0.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 1.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 0.8 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 1.3 | GO:0070695 | FHF complex(GO:0070695) |
0.3 | 1.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 1.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 4.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 1.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 3.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 0.9 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 2.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 2.9 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 0.6 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 3.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 0.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 0.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 1.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.2 | 1.4 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 0.5 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 0.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.2 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.7 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 1.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 1.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 3.7 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 1.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.8 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 1.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 1.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 1.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.7 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.9 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 2.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.6 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 1.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.4 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 1.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 3.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 3.1 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 11.6 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 1.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 1.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.6 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 1.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 2.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.5 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 2.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 1.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 1.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.6 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 2.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.4 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 2.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 1.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 1.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 1.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 2.3 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 1.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.1 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.6 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.3 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 1.0 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 1.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.6 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.3 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.0 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.2 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 23.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.9 | 3.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.6 | 5.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.6 | 3.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.6 | 2.9 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.5 | 2.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.5 | 3.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 1.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.5 | 1.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 1.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 2.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.4 | 1.2 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.4 | 0.8 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.4 | 1.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 1.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.4 | 1.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 1.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 1.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 1.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.3 | 1.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 0.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.3 | 1.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 1.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 0.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 1.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 0.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 2.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 1.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 1.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 2.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 2.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 0.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.3 | 0.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.3 | 1.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 2.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.7 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 1.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.7 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 0.7 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 0.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.7 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 1.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.9 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 0.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 0.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 1.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 0.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 1.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 1.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 1.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 0.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.2 | 0.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 0.8 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 1.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 1.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 0.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.6 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 0.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.2 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.5 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 2.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 0.5 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 0.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 2.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 1.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.2 | 0.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 2.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 1.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.4 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 1.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 0.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 1.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 1.6 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.9 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 1.9 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.4 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 1.4 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.7 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 0.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 2.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.7 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.8 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 2.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 3.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.4 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 1.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 1.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 2.2 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 1.4 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 1.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 1.0 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 1.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 3.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.8 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.0 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.7 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 0.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.5 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 2.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.4 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.1 | 0.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 1.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 2.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 1.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 4.7 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.9 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.4 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 1.2 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 1.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.5 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 1.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.4 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.5 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.6 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0102345 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 1.5 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.2 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.0 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.0 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 2.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.5 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.1 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.3 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 2.6 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 4.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 1.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.3 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.4 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 1.1 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.0 | 0.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 1.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.1 | GO:0043121 | neurotrophin binding(GO:0043121) nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 1.7 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.0 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.0 | 0.0 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.9 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 1.2 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.4 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 2.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 1.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 0.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.0 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.3 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 1.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.9 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 1.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.0 | 0.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 2.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.7 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.0 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.0 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.0 | GO:0043919 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.5 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.1 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 1.4 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.0 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.0 | 0.0 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 2.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 4.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 1.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 1.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 3.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 4.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 5.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 5.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 2.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 3.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 2.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 1.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 2.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 2.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 3.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 2.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 7.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 2.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 3.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.5 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 3.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 2.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.2 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 2.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.6 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.4 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 2.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.6 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 1.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.0 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 2.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.5 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.9 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 1.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 1.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 1.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 1.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.0 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 1.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.0 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |